CA2295023A1 - Solutions containing azasteroids - Google Patents
Solutions containing azasteroids Download PDFInfo
- Publication number
- CA2295023A1 CA2295023A1 CA002295023A CA2295023A CA2295023A1 CA 2295023 A1 CA2295023 A1 CA 2295023A1 CA 002295023 A CA002295023 A CA 002295023A CA 2295023 A CA2295023 A CA 2295023A CA 2295023 A1 CA2295023 A1 CA 2295023A1
- Authority
- CA
- Canada
- Prior art keywords
- solution
- steroid
- composition
- aza
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9717444.5 | 1997-08-19 | ||
GBGB9717444.5A GB9717444D0 (en) | 1997-08-19 | 1997-08-19 | Pharmaceutical composition |
PCT/EP1998/005192 WO1999008684A2 (en) | 1997-08-19 | 1998-08-17 | Solutions containing azasteroids |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2295023A1 true CA2295023A1 (en) | 1999-02-25 |
Family
ID=10817633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002295023A Abandoned CA2295023A1 (en) | 1997-08-19 | 1998-08-17 | Solutions containing azasteroids |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1005346A2 (zh) |
JP (1) | JP2002511100A (zh) |
KR (1) | KR20010014079A (zh) |
CN (1) | CN1263466A (zh) |
AU (1) | AU8979698A (zh) |
BR (1) | BR9810285A (zh) |
CA (1) | CA2295023A1 (zh) |
GB (1) | GB9717444D0 (zh) |
TR (1) | TR199903211T2 (zh) |
WO (1) | WO1999008684A2 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS6633A (is) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Samsetningar af fínasteríð töflum |
CZ300438B6 (cs) * | 2003-11-25 | 2009-05-20 | Pliva Hrvatska D.O.O. | Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu |
JP2007517788A (ja) * | 2004-01-02 | 2007-07-05 | ファルマコン・フォルシュング・ウント・ベラートゥング・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 1,2−不飽和アザステロイド類の製造方法 |
EP2050436A1 (en) | 2007-12-21 | 2009-04-22 | Siegfried Generics International AG | Pharmaceutical composition containing dutasteride |
DE102008059201A1 (de) * | 2008-11-27 | 2010-06-02 | GÖPFERICH, Achim, Prof. Dr. | In situ präzipitierende Arzneistofflösungen |
KR101055412B1 (ko) * | 2010-11-19 | 2011-08-08 | (주)비씨월드제약 | 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법 |
CN103169712B (zh) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | 提高生物利用度的度他雄胺制剂及其制备方法 |
CN104619345A (zh) * | 2012-05-18 | 2015-05-13 | 罗达制药有限公司 | 液体制剂 |
CN103479595B (zh) * | 2012-06-13 | 2015-08-26 | 成都国弘医药有限公司 | 一种含有度他雄胺的软胶囊 |
WO2014002015A1 (en) | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
CN103830201A (zh) * | 2012-11-20 | 2014-06-04 | 重庆医药工业研究院有限责任公司 | 一种度他雄胺液体软胶囊 |
EP2949319A1 (en) | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
JP7017938B2 (ja) * | 2018-01-15 | 2022-02-09 | 森下仁丹株式会社 | 3-オキソ-4-アザアンドロスト-1-エン-17-カルボン酸誘導体含有製剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516768A (en) * | 1990-03-16 | 1996-05-14 | Smithkline Beecham Corporation | Uncompetitive inhibition of steroid and 5α-reductose |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
CA2231434A1 (en) * | 1995-09-27 | 1997-04-03 | Glenn J. Gormley | Method of preventing androgenetic alopecia with 5-.alpha. reductase inhibitors |
WO1998025463A1 (en) * | 1996-12-09 | 1998-06-18 | Merck & Co., Inc. | Methods and compositions for preventing and treating bone loss |
-
1997
- 1997-08-19 GB GBGB9717444.5A patent/GB9717444D0/en active Pending
-
1998
- 1998-08-17 BR BR9810285-0A patent/BR9810285A/pt not_active Application Discontinuation
- 1998-08-17 JP JP51280799A patent/JP2002511100A/ja active Pending
- 1998-08-17 TR TR1999/03211T patent/TR199903211T2/xx unknown
- 1998-08-17 EP EP98941422A patent/EP1005346A2/en not_active Withdrawn
- 1998-08-17 AU AU89796/98A patent/AU8979698A/en not_active Abandoned
- 1998-08-17 KR KR19997012115A patent/KR20010014079A/ko not_active Application Discontinuation
- 1998-08-17 CN CN98806379A patent/CN1263466A/zh active Pending
- 1998-08-17 CA CA002295023A patent/CA2295023A1/en not_active Abandoned
- 1998-08-17 WO PCT/EP1998/005192 patent/WO1999008684A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1005346A2 (en) | 2000-06-07 |
AU8979698A (en) | 1999-03-08 |
WO1999008684A2 (en) | 1999-02-25 |
TR199903211T2 (xx) | 2000-04-21 |
BR9810285A (pt) | 2000-09-12 |
KR20010014079A (ko) | 2001-02-26 |
GB9717444D0 (en) | 1997-10-22 |
CN1263466A (zh) | 2000-08-16 |
WO1999008684A3 (en) | 1999-06-10 |
JP2002511100A (ja) | 2002-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI490216B (zh) | 用作c型肝炎病毒蛋白酶抑制劑之醫藥組合物 | |
KR100425755B1 (ko) | 이트라코나졸을 함유하는 조성물 및 그 제조방법 | |
CA2295023A1 (en) | Solutions containing azasteroids | |
WO2004054540A3 (en) | Solid compositions with improved bio-availability of insoluble or poorly water soluble drugs and a corresponding process for preparing such | |
EP2468262A1 (en) | Pharmaceutical composition comprising dutasteride | |
CA2804635A1 (en) | Formulations of rifaximin and uses thereof | |
JP6276756B2 (ja) | 1,1−ジメチルエチル[(1s)−1−{[(2s,4r)−4−(7−クロロ−4メトキシイソキノリン−1−イルオキシ)−2−({(1r,2s)−1−[(シクロプロピルスルホニル)カルバモイル]−2−エテニルシクロプロピル}カルバモイル)ピロリジン−1−イル]カルボニル}−2,2−ジメチルプロピル]カルバメートの可溶化カプセル製剤 | |
CA2295016A1 (en) | Pharmaceutical composition | |
EP2934591B1 (en) | Solid oral dosage form of testosterone derivative | |
KR20040101300A (ko) | 경질 쉘 캡슐용 이부프로펜 용액 | |
KR101745425B1 (ko) | 두타스테라이드 및 타다라필을 포함하는 경구용 복합제제 에멀젼 조성물 및 그 제조방법 | |
EP3854384A1 (en) | Pharmaceutical formulation comprising abiraterone acetate | |
MXPA99011970A (en) | Pharmaceutical composition | |
MXPA99011995A (en) | Solutions containing azasteroids | |
CA3050347C (en) | Soft gelatin capsules containing h yd roxyp ro pyl beta cyclodextrin with high stability | |
US20030065040A1 (en) | Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle | |
AU7615000A (en) | Vasopressin antagonist formulation and process | |
MX2008002251A (en) | Pharmaceutical formulation with high stability and dissolution and manufacturing process | |
KR20050121497A (ko) | 이트라코나졸의 경구투여용 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |